HTFL - Company ID 0001464521
Heartflow, Inc. trades as HTFL and has a market capitalization of $2.39 B, making it the #2008 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $176.03M, up 39.9% from the prior year and net income of -$116.79M. This page tracks Heartflow, Inc. through 126 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Net profit margin expanded from -109.7% to -66.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Insider trade | 4 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-05-11 |
Total revenue of $52.6 million, a 41% increase year-over-year
Those interested in listening to the conference call should register online using this link . Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A live and archived webcast of the event will also be available on the “Investor Relations” section of the Heartflow website at https://ir.heartflow.com/ . The archived version will be available for 12 months following completion of the live call.
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform
Total revenue of $49.1 million, a 40% increase year-over-year
Three presentations at ACC reinforce Heartflow’s AI-powered technology predicts MACE, drives superior lipid outcomes and results in cost-effective care
The largest companies sharing Heartflow, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
Heartflow, Inc. (HTFL) has a market capitalization of $2.39 B as of 2026-07-09, ranking #2008 among US-listed companies.
Heartflow, Inc. reported revenue of $176.03M for fiscal year 2025, an increase of 39.9% year over year.
In its latest fiscal year Heartflow, Inc. reported a net loss of $116.79M.